tirzepatide type 2 diabetes monotherapy in Chinese patients with early diabetes: A randomized, double-blind, placebo-controlled phase 3 trial (SURPASS-CN-MONO) Eli Lilly's Zepbound reduces type
Pay in 4 interest-free payments of $5.21 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26




























